1. Home
  2. CGEM vs MBUU Comparison

CGEM vs MBUU Comparison

Compare CGEM & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • MBUU
  • Stock Information
  • Founded
  • CGEM 2016
  • MBUU 1982
  • Country
  • CGEM United States
  • MBUU United States
  • Employees
  • CGEM N/A
  • MBUU N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • MBUU Marine Transportation
  • Sector
  • CGEM Health Care
  • MBUU Industrials
  • Exchange
  • CGEM Nasdaq
  • MBUU Nasdaq
  • Market Cap
  • CGEM 506.1M
  • MBUU 582.6M
  • IPO Year
  • CGEM 2021
  • MBUU 2014
  • Fundamental
  • Price
  • CGEM $7.89
  • MBUU $27.01
  • Analyst Decision
  • CGEM Strong Buy
  • MBUU Hold
  • Analyst Count
  • CGEM 7
  • MBUU 7
  • Target Price
  • CGEM $32.86
  • MBUU $36.80
  • AVG Volume (30 Days)
  • CGEM 520.6K
  • MBUU 264.5K
  • Earning Date
  • CGEM 05-14-2025
  • MBUU 05-01-2025
  • Dividend Yield
  • CGEM N/A
  • MBUU N/A
  • EPS Growth
  • CGEM N/A
  • MBUU N/A
  • EPS
  • CGEM N/A
  • MBUU N/A
  • Revenue
  • CGEM N/A
  • MBUU $733,991,000.00
  • Revenue This Year
  • CGEM N/A
  • MBUU N/A
  • Revenue Next Year
  • CGEM N/A
  • MBUU $11.55
  • P/E Ratio
  • CGEM N/A
  • MBUU N/A
  • Revenue Growth
  • CGEM N/A
  • MBUU N/A
  • 52 Week Low
  • CGEM $6.85
  • MBUU $24.43
  • 52 Week High
  • CGEM $30.19
  • MBUU $47.82
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 47.24
  • MBUU 41.88
  • Support Level
  • CGEM $6.93
  • MBUU $25.67
  • Resistance Level
  • CGEM $8.10
  • MBUU $28.20
  • Average True Range (ATR)
  • CGEM 0.52
  • MBUU 2.04
  • MACD
  • CGEM 0.07
  • MBUU -0.02
  • Stochastic Oscillator
  • CGEM 83.20
  • MBUU 35.58

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About MBUU Malibu Boats Inc.

Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is the market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the us in the 24- to 29-foot segment, in 2017 and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a leading seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.

Share on Social Networks: